查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387493

血糖监测系统市场报告：2030 年趋势、预测与竞争分析

Blood Glucose Monitoring System Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

血糖监测系统的趋势和预测

预计到 2030 年，全球血糖监测系统市场将达到 345 亿美元，2024 年至 2030 年年复合成长率为 7.5%。该市场的主要驱动因素是糖尿病盛行率的增加、高龄化导致的糖尿病易感性增加、新产品的发布以及糖尿病预防意识的提高。全球血糖监测系统市场的未来充满希望，指尖和替代站点市场存在机会。

血糖监测系统市场洞察

Lucintel 预测，由于糖尿病患者数量不断增加以及人们对定期监测血糖水平的意识不断增强，居家照护在预测期内仍将是最大的细分市场。

由于肥胖率上升、医疗成本高、新产品推出和技术改进，北美在预测期内将继续成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球血糖监测系统市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球血糖监测系统市场趋势（2018-2023）与预测（2024-2030）
  • 按测试地点分類的全球血糖监测系统市场
    • 指尖
    • 替代网站
  • 全球血糖监测系统市场（按产品）
    • 自我监控
    • CGMS
  • 按患者照护的全球血糖监测系统市场
    • 医院
    • 居家照护
  • 全球血糖监测系统市场（按应用）
    • 类型1
    • 2型
    • 妊娠糖尿病
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球血糖监测系统市场（按地区）
  • 北美血糖监测系统市场
  • 欧洲血糖监测系统市场
  • 亚太地区血糖监测系统市场
  • 其他地区血糖监测系统市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按测试地点分類的全球血糖监测系统市场的成长机会
    • 全球血糖监测系统市场成长机会（按产品）
    • 患者照护的全球血糖监测系统市场成长机会
    • 全球血糖监测系统市场成长机会（按应用）
    • 全球血糖监测系统市场成长机会（按地区）
  • 全球血糖监测系统市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球血糖监测系统市场的产能
    • 全球血糖监测系统市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
简介目录

Blood Glucose Monitoring System Trends and Forecast

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

A more than 150-page report is developed to help in your business decisions.

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Shipment Analysis by Value from 2018 to 2030]:

  • Fingertip
  • Alternate Site

Blood Glucose Monitoring System Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Self-Monitoring
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Homecare

Blood Glucose Monitoring System Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Type 1
  • Type 2
  • Gestational Diabetes
  • Others

Blood Glucose Monitoring System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Blood Glucose Monitoring System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies blood glucose monitoring system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Blood Glucose Monitoring System Market Insights

Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing site, product, patient care setting, application, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the blood glucose monitoring system market size?

Answer: The global blood glucose monitoring system market is expected to reach an estimated $34.5 billion by 2030.

Q2. What is the growth forecast for blood glucose monitoring system market?

Answer: The global blood glucose monitoring system market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the blood glucose monitoring system market?

Answer: The major drivers for this market are growing prevalence of diabetes, aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

Q4. What are the major segments for blood glucose monitoring system market?

Answer: The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets.

Q5. Who are the key blood glucose monitoring system market companies?

Answer: Some of the key blood glucose monitoring system companies are as follows:

  • Thermo Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which blood glucose monitoring system market segment will be the largest in future?

Answer: Lucintel forecasts that homecare will remain the largest segment over the forecast period due to rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.

Q7. In blood glucose monitoring system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Blood Glucose Monitoring System Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Blood Glucose Monitoring System Market by Testing Site
    • 3.3.1: Fingertip
    • 3.3.2: Alternate Site
  • 3.4: Global Blood Glucose Monitoring System Market by Product
    • 3.4.1: Self-Monitoring
    • 3.4.2: Continuous Glucose Monitoring Devices
  • 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 3.5.1: Hospital
    • 3.5.2: Homecare
  • 3.6: Global Blood Glucose Monitoring System Market by Application
    • 3.6.1: Type 1
    • 3.6.2: Type 2
    • 3.6.3: Gestational Diabetes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Blood Glucose Monitoring System Market by Region
  • 4.2: North American Blood Glucose Monitoring System Market
    • 4.2.2: North American Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.3: European Blood Glucose Monitoring System Market
    • 4.3.1: European Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.3.2: European Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.4: APAC Blood Glucose Monitoring System Market
    • 4.4.1: APAC Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.4.2: APAC Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare
  • 4.5: ROW Blood Glucose Monitoring System Market
    • 4.5.1: ROW Blood Glucose Monitoring System Market by Testing Site: Fingertip and Alternate Site
    • 4.5.2: ROW Blood Glucose Monitoring System Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
    • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
    • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
    • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
  • 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott